VION Pharmaceuticals Inc.

Public Company, Headquarters Location
4 Science Pk., New Haven, CT 06511-1963, United States
(203)498-4210, (203)498-4211 fax, http://www.vionpharm.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Manufactures pharmaceuticals to treat cancer. Services: Research, development and commercialization of cancer therapeutics and technologies.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

VION Pharmaceuticals Inc., News and Information

Seaside Therapeutics Appoints Tanya Lewis to the Key Position of Vice President, Regulatory Affairs and Quality Assurance.
Clinical Trials Week; 1/4/2010; 886 words; ...Affairs and Quality Assurance for Vion Pharmaceuticals, Inc. and prior positions include leadership roles at Millennium Pharmaceuticals Inc. (later acquired by Takeda Pharmaceutical Company Limited ) and Genzyme Corporation...

Vion Pharmaceuticals Files for Chapter 11 Bankruptcy.
Blood Weekly; 12/31/2009; 1151 words; VION PHARMACEUTICALS, INC. (BULLETIN BOARD: VION) , a pharmaceutical company focused on the...Pharmaceutical Business, Pharmaceutical Company, Pre-Trials...Drug Administration, Vion Pharmaceuticals Inc. This article was prepared...

News and FDA Updates for Vitro (OTC:VODG), Vion (OTC:VION), Warner Chilcott (Nasdaq:WCRX).
M2 Presswire; 12/31/2009; 977 words; ...BioMedReports.Com On 12/30/09, Vitro Diagnostics, Inc. (OTC:VODG), dba Vitro Biopharma, announced...a prior private placement. On 12/30/09, Vion Pharmaceuticals, Inc. (OTC:VION), announced the U.S. Food and Drug Administration...

Other News To Note.
BIOWORLD Today; 12/31/2009; 915 words; ...of CBLC102. o Cyclacel Pharmaceuticals Inc., of Berkeley Heights...Pharmaceuticals International Inc., of Aliso Viejo, Calif...o VIA Pharmaceuticals Inc., of San Francisco...Counter Bulletin Board. o Vion Pharmaceuticals Inc...

Vion Pharmaceuticals Receives Complete Response Letter for Onrigin From the U.S. Food and Drug Administration.
Cancer Weekly; 12/29/2009; 680 words; ...issues (see also Vion Pharmaceuticals, Inc.). Alan Kessman...information on Vion and its product...Oncology, Pharmaceutical Business, Pharmaceutical Company, Regulatory...Administration, Vion Pharmaceuticals Inc. This article...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.